Knockdown of LRRK2 inhibits the progression of lung cancer by regulating TLR4/NF- κB pathways and NLRP3 inflammasome

In conclusion, this study suggested that the mechanism of si-LRRK2 inhibiting the progression of lung cancer is to regulate the TLR4/NF-κB signaling pathways and NLRP3 inflammasome.PMID:37970545 | PMC:PMC10636582 | DOI:10.3164/jcbn.22-122

Source: Clinical Biochemistry - November 16, 2023 Category: Biochemistry Authors: Junfang Wu Shumei Yang Hua Wu Yongcheng Huang Yi Miao Source Type: research